1. Home
  2. Live Updates
  3. Biopharmaceuticals

Live Breaking News & Updates on Biopharmaceuticals

Stay informed with the latest breaking news from Biopharmaceuticals on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Biopharmaceuticals and stay connected to the pulse of your community

CymaBay Therapeutics 4Q Loss/Shr 35c >CBAY

Please disregard the headline "Gilead Sciences Proposed to Acquire CymaBay for $32.50 Per Shr in Cash or a Total Equity Value of $4.3B," at 4:46 p.m. ET. The...

Gilead-sciences-proposed-to-acquire-cymabay , Sciences-proposed , Acquire-cymabay , Total-equity-value , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Synd , Cymabay-therapeutics

Viking Therapeutics offers new shares after stock soars

Viking Therapeutics has a stock offering starting at $85 — a discount from its Wednesday closing price of $94.50.

Novo-nordisk-wegovy , Jason-mccarthy , Akash-tewaria , Lilly-mounjaro , Naz-rahman , Eli-lilly-co , Therapeutics-inc , Viking-therapeutics-inc , Eli-lilly , Novo-nordisk , Article-normal , Biotechnology

Milestone Pharmaceuticals Shares Fall Premarket After Stock Offering

By Colin Kellaher Shares of Milestone Pharmaceuticals slid more than 20% in premarket trading after the biopharmaceutical company said it was raising $30...

Montreal , Quebec , Canada , Colin-kellaher , Milestone-pharmaceuticals , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Financial-performance , Share-price-movement-disruptions

Madrigal Pharmaceuticals Replaces Chief Financial Officer

By Colin Kellaher Madrigal Pharmaceuticals has hired Mardi Dier to replace Alex Howarth as chief financial officer of the clinical-stage biopharmaceutical...

Alex-howarth , Colin-kellaher , Madrigal-pharmaceuticals , Mardi-dier , West-conshohocken , Article-normal , Biotechnology-services , Pharmaceuticals , Cancer-drugs , Healthcare-life-sciences , Biopharmaceuticals , Specialized-drugs-medications

Health Care Slips on Growth Doubts -- Health Care Roundup

Health-care companies slipped amid doubts about the outlook for growth. Lawyers for biopharmaceutical company Sorrento Therapeutics disputed allegations that...

Texas , United-states , Rob-curran , Novo-nordisk , Sorrento-therapeutics , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Corporate-industrial-news , Political-general-news

Janux Shares Double After Positive Data From Ongoing Trials

By Stephen Nakrosis Shares of Janux Therapeutics doubled after hours Monday, following the release of data from ongoing dose escalation trials for...

Stephen-nakrosis , Janux-therapeutics , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Biological-therapy , Healthcare-provision , Financial-performance , Share-price-movement-disruptions

Viking Therapeutics' stock soars 61% premarket after company reports positive results in trial of weight-loss drug

Viking posted positive results from a mid-stage trial of its GLP-1 drug.

Drug-administration , Therapeutics-inc , Viking-therapeutics , Article-normal , Biotechnology , Pharmaceuticals , Machinery , Agricultural-machinery , Health-care , Biopharmaceuticals , Specialized-drugs-medications

Viking Therapeutics Stock Surges 100% on Positive Weight-Loss Drug Trial

Patients saw ‘significant’ reductions in body weight during a study of a weight-loss drug developed by Viking Therapeutics.

United-states , American , Eli-lilly , Karishma-vanjani , Novo-nordisk , Viking-therapeutics , Article-normal , Biotechnology-services , Pharmaceuticals , Machinery , Agricultural-machinery , Healthcare-life-sciences

Arcutis Biotherapeutics Shares Up on 4Q Narrowed Loss, Revenue Beat

By Adriano Marchese Arcutis Biotherapeutics shares were higher ahead of the morning trading bell Tuesday after the company reported better-than-expected...

Frank-watanabe , Arcutis-biotherapeutics , Adriano-marchese , Executive-frank-watanabe , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Biological-therapy , Healthcare-provision

Viking Therapeutics' stock doubles as investors cheer cheap entry to weight-loss drug craze

Viking posted positive results from a mid-stage trial of its GLP-1 drug.

Therapeutics-inc , Viking-therapeutics , Article-normal , Biotechnology , Pharmaceuticals , Machinery , Agricultural-machinery , Health-care , Biopharmaceuticals , Specialized-drugs-medications , Hormone-products